the rhode island latino cancer control task force (lcctf)
DESCRIPTION
Assessing Cancer Registry Systems: Challenges and Opportunities for Improving Outreach in Rhode Island Minority Populations. The Rhode Island Latino Cancer Control Task Force (LCCTF) Bridging the Health Care Divide: Research and Programs to Eliminate Cancer Disparities. - PowerPoint PPT PresentationTRANSCRIPT
Assessing Cancer Registry Systems: Challenges and Opportunities for Improving Outreach in Rhode Island Minority Populations
The Rhode Island Latino Cancer Control Task Force (LCCTF)
Bridging the Health Care Divide: Research and Programs to Eliminate Cancer Disparities
American Cancer Society Conference New Orleans, Louisiana
April 18-20, 2007
2
Building a Coalition
2000 General Assembly urges Rhode Island cities and towns to create municipal Cancer Control Task Forces.
Established partnership among American Cancer Society, RIDOH, RICAN
13 coalitions were formed.
3
Building a Coalition
Neither one focused on dispair populations.
Hispanic/Latinos are the majority of the minority groups in RI, representing almost 12% of the overall population.
Among the Hispanic/Latino population, Cancer was the leading cost of death during the period of 1999-2004 in the State of Rhode Island.
4
Building a Coalition
The Formation of the Latino Cancer Control Task Force will help: to determine the nature of cancer challenge in
our community, to examine its causes, and to identify resources, gaps and opportunities,
in order to develop prioritized strategies that will diminish the cancer deaths among the Latino community in our state.
5
Building a Coalition
October 20, 2005, The Latino Cancer Control Task Force
(LCCTF) was created as a volunteer-based Community group formed
in response to the need to reduce the leading causes of cancer morbidity and
mortality among Hispanic/Latinos in Rhode Island.
6
The Latino Cancer Control Task Force Mission Statement
The Latino Cancer Control Task Force aims to reduce the impact of cancer in the Latino
community in Rhode Island
by facilitating cancer prevention through outreach, public education, awareness, early
detection, access to care and advocacy,
and improving care and quality of life for cancer patients, their families, and caregivers.
7
The Latino Cancer Control Task ForceGoals and Objectives
Advocacy. Being vigorous advocates for cancer control, supporting public policy initiatives and research, and developing strategic alliances with governmental agencies, hospitals, nongovernmental health promotion organizations, health professionals, the community, and the media.
Outreach. Providing outreach targeting the different populations, institutions, providers, policy makers, advocates, community leaders and organizations to increase knowledge and awareness of cancer issues affecting Latinos.
8
The Latino Cancer Control Task Force Goals and Objectives
Education. Preventing cancer by increasing knowledge and awareness of cancer and by encouraging healthier behaviors.
Services. Promoting the early detection of cancer through public education and access to screenings and treatment.
Quality of life. Improving patients' quality of life and minimizing their suffering through education, support, and palliative care.
9
The Latino Cancer Control Structure
Co-Chairs(2)
Data AnalysisWorkgroup
OutreachWorkgroup
Policy & Advocacy
Workgroup
MediaWorkgroup
Secretary Treasurer
10
LCCTF Projects
Conduct an assessment on what resources are available to the Hispanic/Latino population.
Assess how data is collected and interpreted by regulatory offices.
Bring together Latino health professionals to educate and create community awareness on the issues of cancer prevention and early detection.
Trough our Advocacy workgroup support American Cancer Society Legislative Policy Priorities.
Ensure fair access to screenings and treatment.
11
LCCTF Accomplishments
Membership: LCCTF membership represents the vast diversity of Latinos in RI.
Data Analysis: Data Analysis workgroup conducted a survey to all RI Hospitals.
1st. Annual Conference “Mujeres Hablemos Claro! La Salud del Seno” 183 registered, 126 attended, 60 new volunteers, 13 “De Amiga a Amiga” volunteers trained.
Legislation Introduced by one of LCCTF members Senator Juan Pichardo, asking to increase the funds for the WCSP.
12
LCCTF Data Systems Project
Assess how data is collected and interpreted by regulatory offices
The Rhode Island Cancer Registry System Study
13
The RICR System Study -Objectives
Conduct an assessment of the Rhode Island Cancer Registry (RICR) System
Determine how race and ethnicity information of cancer patients is collected and reported
Identify strengths, limitations and opportunities for improving CR information quality and data utilization for population targeting and outreach
14
Main Questions
What are the start and end-points of the RI CR?
What is the guideline?
Is there compliance with OMB 15?What are the implications of non-uniform reporting?
Other study findingsCan under-reporting be corrected?
15
Start and End-Points - RICR
Cancer Patients
DATA SYSTEM
COLLECTION AGGREGATION LOCAL, REGIONAL AND NATIONAL REPORTING
Cancer Patients/Cancer
Families
16
What is the Guideline?
The Rhode Island Department of Health requires healthproviders to collect the following demographic information about their patients:
What is your ethnic background? Hispanic/Latino Not Hispanic/Latino
What is your race? (please indicate all races that apply) American Indian or Alaskan Native
Asian Black or African American Native Hawaiian or other Pacific Islander White
17
OMB 15
Is there compliance in the collection and reporting of race and ethnicity?
18
RICRS Assessment - Methods
Hospital Survey 14 acute care hospitals13 cancer registries hospital cancer registry data not a start or end-point
Key Informant Interviews3 key informantspublic health, health care industry and national voluntary health organization
19
Hospital Cancer Registry Survey
Unit of Analysis: hospitals (information collected via questionnaire)
Population of Interest: Rhode Islanders with a diagnosis of primary cancer
Main Topics: forms used for cancer patient intake, collection of cancer risk factors and race/ethnicity information, content of database and access to cancer registry data, feasibility of CR and MR linkage, frequency of reports and organizations receiving reports (22 questions)
20
Participating Hospitals (N=14)
Kent Hospital Landmark Medical Center Memorial Hospital of Rhode Island Miriam Hospital Naval Health Care New England Newport Hospital Rhode Island Hospital Roger Williams Medical Center South County Hospital St. Joseph Hospital Our Lady of Fatima Hospital VA Medical Center Westerly Hospital Women & Infants Hospital
21
Key Informant Interviews
Unit of Analysis: individual expertise in cancer data systems (information collected via questionnaire)
Population of Interest: US population with a diagnosis of primary cancer
Main Topics: reporting organizations, types/ format of information reported, risk factor and race/ethnicity information quality, methods for adjusting under-reporting, OMB compliance, database content and access to cancer registry data, feasibility of CR and MR linkage, frequency of reports and agencies targeted (26 questions)
22
Key Informants (N=3)
John Fulton, PhD Director, Rhode Island Cancer Registry Associate Director of Health Rhode Island Department of Health
David Rousseau, PhD Director, Cancer Information Systems Hospital Association of Rhode Island
Jimmy Parson, PhD Research and Analysis Manager American Cancer Society, NHO
23
Analysis
Hospital Survey Since sample size was small, results are presented as frequencies and percents Because some questions asked for more than
1 response, some figures exceed the total number of expected responses
Responses were converted into ordinal scales (i.e.; all=100%; most=70-99%; some=40-69%; a few=1-39%; none=0%) Ordinal scales were grouped by topic in order
to summarize findings
24
Analysis
Key Informant InterviewsEmphasis set on the qualitative aspects of informationResults not presented in frequencies or percents Information used to gain a better insight into
hospital survey results and inform discussion of findings and recommendations to 1) help improve the quality of cancer registries and 2) translate findings into improved outreach
practices
25
Results Hospital Survey
Summary 14 Rhode Island hospitals have cancer registries Requested participation of hospital cancer
registrars Respondents signed consent form 1 initial mailing and two respondent follow-ups 11 hospital cancer registries responded (79%
response rate) Findings presented here exclude non-respondents Respondent follow-up ended 04-16-07 2 hospitals share the same reporting system
26
Results Hospital Survey
Forms Do hospitals with CRs have intake forms (IF)
specific for cancer?5 hospitals (45%) have an IF for cancer; 5 hospitals
(45%) use a general IF Is information on cancer risk factors obtained via
cancer IF?3 hospitals (30%) collect cancer risk factor
information on these forms Is other form used to obtain cancer risk factor
information?6 hospitals (56%) use other sources
27
Results Hospital Survey (cont.)
Forms What form is used to determine the race of cancer patients?
10% (1 out of 4 with cancer intake forms) ask for race
5 hospitals (50%) ask for race thru general intake forms
4 hospitals (40%) use other forms (medical records, physical exam, medical history)
28
Results Hospital Survey (cont.)
Forms What form is used to determine the ethnicity of cancer patients?
11% (1 out of 4 with cancer intake forms)
4 hospitals (44%) use general intake forms
4 hospitals (44%) use other forms
2 hospitals did not respond to this question
29
Results Hospital Survey (cont.)
FormsFrom findings presented so far: race (50%) and
ethnicity (56%) are obtained via intake forms by
40% of hospitals with cancer registries
How many races can be checked in the intake form?
1 race: 1 hospital (9%)2 races: 2 hospitals (18%)2 or more races: 4 hospitals (36%)
4 hospitals (36%) do not collect this information in the intake form
30
Results Hospital Survey (cont.)
Forms
What form is used to determine the country of origin of cancer patients?
1 hospital (11%) uses the cancer intake form to obtain information on country of origin
8 hospitals (88%) reported not collecting information on country of origin
31
Results Hospital Survey (cont.)
Race/Ethnicity/Country of Origin How is the race of a cancer patient determined? (multiple response question)
a. In 4 hospitals (36%) patient self-reports race
b. In 5 hospitals (45%) person filling form asks patient
c. In 1 hospital (9%) person filling form makes a guess
d. In 4 hospitals (36%) information obtained from MR
e. 1 hospital (9%) uses medical history/physical exam 2 hospitals use a combination of methods b and d 1 hospital use a combination of methods b and c
32
Results Hospital Survey (cont.)
Race/Ethnicity/Country of Origin
How is the ethnicity of a cancer patient determined? (multiple response question)
a. 3 hospitals (27%) present the patient with a standard form and the question “Are you from Hispanic or Latino origin”
b. 6 hospitals (56%) ask patients about their ethnicity in a non-standard way
c. 2 hospitals (18%) reported “unknown”
33
Results Hospital Survey (cont.)
Access to Cancer Data
Does the intake form have a number that can be used to link with the patient medical record?
All (7 out of 7 hospitals with intake forms) can link to MRs
Do hospitals aggregate information of cancer cases (from intake and other forms) into a database?
All (11 out of 11 hospitals)
34
Results Hospital Survey (cont.)
Access to Cancer Data
Is cancer data available to researchers from academic institutions?
10 hospitals (91%) provide access to cancer data
Is there an internal procedure to obtain access?
10 hospitals (91%) have an IRB process in place
35
Results Hospital Survey (cont.)
Reporting To what organizations do you report cancer data?
5 hospitals (45%) to NCBD (National CAHPS Benchmarking Database); yearly 1 hospital (9%) to CIRF (Cancer Information Reference
File); yearly4 hospitals (36%) to the National Cancer Database of the American College of Surgeons (ACS); yearlyAll to the Rhode Island Cancer Registry (RICR); monthlyAll to the Hospital Association of Rhode Island (HARI); monthly
36
Results Hospital Survey (cont.)
Reporting
Is the data you report linked to medical records?
4 hospitals (37%) have MR linkage capacity
37
Key Informant Results
TOPIC HARI RI CR ACSWho reports; 13 hospital CR; 21 Century 13 hospital CR; 6 state CR; Americans for Non-Smokershow often? Oncology Services (monthly) pathology labs; surgical Rights; National Breast and
centers (monthly) Cervical Cancer Early
Detection Program; Tobacco Free Kids; National Committee for Quality Assurance (NCQA), Colorectal Screenings in
Health Plans; UC Berkeley, Smoking Cessation for Medicaid; Smoke Free Grade, American Lung
Association; Cancer Incidence Rates, National Program of Cancer Registries; Behavioral Risk Factor Surveillance System (BRFSS) and Youth Risk Factor Surveillance System (YRBFS) (all yearly)
38
Key Informant Results (cont.)
TOPIC HARI RI CR ACS
Data format single format: North single format (NAACCR) multiple formats (excel,American Association word, pdf and text)of Central Cancer Registries (NAACCR)
Database www.naaccr.org www.naaccr.org n/aSpecifications
Cancer risk smoking status and no cancer RF data smoking; Thompson MedstatFactors (RF) occupation PULSE Survey
Screening no screening data no screening data breast and colorectal screen.
Race/ethnicity yes yes yes
# of races most report 1 race most report 1 race (“can most report 1 raceReported report up to six”)
Information on no some; “this is a variable in no how is race the NCAACCR data set, but determined? HEALTH does not require it”
39
Key Informant Results (cont.)
TOPIC HARI RI CR ACS
Information on no no a fewhow ethnicity isdetermined?
Do you provide “Race and ethnicity treated When directed by feds “We only look at race/
guidance to like all other data items When required by state ethnicity data forcomply with required by law” When requested by hospitals screening data and
dataOMB 15? When required by RI HARI coming from CDC”
Target year for no “It’s being discussed but no responsehelping partners no date yet”achieve OMB 15compliance?
Organizations -NAACCR -NAACCR -ACS Divisions
(monthly)you report data -National Program of -CDC -ACS Management (asto? Cancer Registries (CDC) -International Association needed)
-RI Department of Health of Cancer Registries (IACR)-Central Brain Tumor (yearly)
Registry of United Sates (CBTRUS); (yearly)
40
Key Informant Results (cont.)
TOPIC HARI RI CR ACS
Uses Spanish Uses NAACCR algorithm “We can do this, but as a “We don’t go into that levelsurname method (last name + place of birth) separate variable…we of detail in our reporting.to adjust to determine Hispanic don’t report it to CDC, We rely on externalunder-reporting? sources”
How do you 1 race + ethnicity (“2nd “Several formats per 1 race + ethnicity report data on racial group almost never request“race/ethnicity? recorded in medical
Do you keep yes yes “Not to my knowledge. Weidentifiers to link have worked with ACoS tocancer registry determine underserved inand MR data? hospitals but it is not
possible to link up”
Is your data yes yes “We dot provide this dataavailable to IRB approval may be at this time”researchers? necessary
41
Key Informant Results (cont.)
TOPIC HARI RI CR ACS
How many data blank 6 data inquiries 0inquiries and [Note: research proposals 0 research are handled by the IRBproposals do Committee]receive per year?
Is there an IRB yes yes blankprocedure?
What cancer Contact Dr. John Fulton -Annual Report -Mission Scorecard (yearly)
reports does your -RI Cancer Burden -Mission Dashboard (yearly)
organization (annual update) -Best Practices Reports produce? -Special reports (ongoing) (ongoing)
Do you report yes yes yes cancer data within yourorganization?
42
RI CR Assessment: Start/End-Points
Naval HC NE
Miriam H.
Memorial H RI
Landmark MC
Kent H.
Newport H.
Rhode Island H.
R. Williams MC
South County H.
St .Joseph H.
Our Lady of Fatima
VA MC
Westerly H.
Women & Infants.
Hospitals CRs1
2
3
4
5
6
7
8
9
10
11
12
13
HARI
RI CR
6 states
pathology labs, surgical centers
21st Century Oncology Services
Cancer Patients
CDC
NAACCR
CBTRUS
CDC
NAACCR
IACR
ACS
NCQA
Colorectal Screenings in Health Plans
ALA
BRFSSYBRFS
NPCR
ACS Divisions
ACS Management
Cancer Patients/Cancer
Families/Communities
43
Compliance with OMB 15?
Findings from the hospital cancer registry survey indicated lack of uniform collection of information on race and ethnicity.
Only a few hospitals ask patients to self-report their race (27%) and ethnicity (27%) according to the guideline Only a few hospitals (36%) collect information on 2 or more races
The Key Informant Interview revealed that most cancer data sources only report 1 race
There is no target date yet in RI for achieving OMB 15 compliance with cancer data reporting
44
Summary of Findings 1. Use of Intake Forms (IFs) specific to cancer2. Use of IFs (cancer-specific and general)3. Use of IFs to obtain cancer risk factor (CRF) information4. Use of other forms to obtain CRF information5. Collection of CRF information from all sources6. Is reporting of CRF information a RI CR requirement?7. Race information obtained at point of entry (POE)8. Race information obtained from other sources9. Ethnicity information obtained at POE10. Ethnicity information obtained from other sources11. RI CR mechanism to monitor OMB 15 compliance?12. Collection of information on country of origin13. IF/MR linkage14. RI CR/MR linkage15. Patient self-reporting of race and ethnicity16. Collection of information of two or more races17. Reporting of two or more races18. Target date for OMB 15 compliance?19. Cancer data available/IRB process in place
45
Summary of Findings 1.
2.
3. 4.
5.
6. NO 7.
8. 9.
10.11. NO12.
13.14.
15.
16.
17.
18. NO
19.
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
??
45%91%
30%60%
90%
91%
60%40%
56%44%
12%100%
9%
37%27%
36%
Hospital Cancer Registry SurveyKey Informant Interview
46
Implications of Non-Compliance
Undercount of multi-racial ethnic groups; over count of non multi-racial ethnic groupsUnderestimates in cancer prevalence, incidence and mortalityProblem may not be limited to the RI CRS; other RI/national data sets may be affectedDifficult targeting and outreach of multi- racial ethnic groupsMisdirecting resources for targeting/outreachPotential for unsound public health practice
47
Other Study Conclusions
All = 100%; Most = 70-99%; Some = 40-69%; A few = 1-39%; None = 0%
The form closest to the information entry point is the IF
Most hospitals (91%) reported use of IFsA few hospitals (30%) use IFs to collect information
on cancer risk factors (RFs)Some hospitals (60%) use other forms
While some cancer RF information is obtained at the point of entry, the Key Informant Survey revealed no reporting requirement
48
Other Study Conclusions (cont.)
All = 100%; Most = 70-99%; Some = 40-69%; A few = 1-39%; None = 0%
About half of the information on race and ethnicity obtained at the point of entry (IF)
Some hospitals (60%) obtain race information thru IFs; some hospitals (56%) use IFs for ethnicityA few hospitals (40%) use other forms to determine race and some (44%) for ethnicity
The Key Informant Survey determined that:There is no mechanism in the RI CR system to monitor OMB 15 complianceNo information is reported on how race and ethnicity data are collected
49
Other Study Conclusions (cont.)
All = 100%; Most = 70-99%; Some = 40-69%; A few = 1-39%; None = 0%
Most hospitals (88%) do not collect information on country of origin
1 asks for country of origin1 asks for main language
All hospitals with IFs can link back to MRs; only a few hospitals (37%) can link back to MRs data reported to the RI CR
However, HARI and the RI CR require a field in reported databases that can be used to link to MRs
50
Can the Problem be Fixed?
Our recommendations:
Improve data quality at the point of entry and monitor data quality collection and reporting on key variables including race and ethnicity
In the interim, promote use and refinement of the Spanish Surname Algorithm to determine the extent of the undercount of Hispanic cancer cases and institutionalize dissemination of more reliable cancer statistics
51
Apply the Guideline Please
52
Contact Information
Alvaro M Tinajero, MD, MPH, [email protected]@[email protected]
Mercedes (Betty) [email protected]